AU Patent

AU2023219901A1 — Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist

Assigned to Glaxo Group Ltd · Expires 2023-09-14 · 3y expired

What this patent protects

A composition comprising a compound of the formula: 0 N X OH Compound (1) wherein X- is a pharmaceutically acceptable anion; and a compound of the formula: HOCH CI HO: / CHCH 2NH(CH 2),0(CH2)2OCH2 OH CI or a pharmaceutically acceptable salt thereof (Compound (11)).

USPTO Abstract

A composition comprising a compound of the formula: 0 N X OH Compound (1) wherein X- is a pharmaceutically acceptable anion; and a compound of the formula: HOCH CI HO: / CHCH 2NH(CH 2),0(CH2)2OCH2 OH CI or a pharmaceutically acceptable salt thereof (Compound (11)).

Drugs covered by this patent

Patent Metadata

Patent number
AU2023219901A1
Jurisdiction
AU
Classification
—
Expires
2023-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.